Recombinant Soluble Glypican 3 Protein Inhibits the Growth of Hepatocellular Carcinoma in Vitro

International Journal of Cancer - United States
doi 10.1002/ijc.25549
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2014English

First-In-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients With Advanced Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells

PLoS ONE
Multidisciplinary
2015English

Fn14•Trail Effectively Inhibits Hepatocellular Carcinoma Growth

PLoS ONE
Multidisciplinary
2013English

Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2015English

Radiofrequency Ablation for Hepatocellular Carcinoma Induces Glypican-3 Peptide-Specific Cytotoxic T Lymphocytes

International Journal of Oncology
Cancer ResearchOncology
2011English

Alpha-Fetoprotein, Alpha-Fetoprotein-L3, Protein Induced by Vitamin K Absence, Glypican 3 and Its Combinations for Diagnosis of Hepatocellular Carcinoma

Surgery, Gastroenterology and Oncology
OncologySurgeryGastroenterology
2019English

The Combination of Ulinastatin and 5-Fluorouracil Synergistically Inhibits Hepatocellular Carcinoma Growth

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

USP39 Promotes the Growth of Human Hepatocellular Carcinoma in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy